Assessment of two different diagnostic guidelines criteria (National Cholesterol Education Adult Treatment Panel III [ATP III] and International Diabetes Federation [IDF]) for the evaluation of metabolic syndrome remission in a longitudinal cohort of patients undergoing Roux-en-Y gastric bypass

Rodríguez-Ortiz, Donají; Reyes-Pérez, Azucena; Leon, Pablo Mendes de; Sánchez, Hugo; Mosti, Maureen; Aguilar-Salinas, Carlos A.; Velázquez-Fernández, David; Herrera, Miguel F.

doi:10.1016/j.surg.2015.11.015

Cited by 26 publications

(18 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Adipokines, which are involved in both insulin resistance and chronic inflammation, have also been demonstrated to contribute to the pathogenesis of abnormal metabolic factors, including obesity, diabetes, hyperlipemia, and high BP (34,35). The dysregulation of adiponectin, the most abundant adipokine (36), does not only play a role in metabolic syndrome but also in breast cancer (37). Our previous meta-analysis and epidemiological results confirmed that a higher circulating high-molecular-weight (HMW) adiponectin (known as the active form) decreased breast cancer risk, especially in postmenopausal women (38,39).…”

Section: Introductionmentioning

confidence: 99%

Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case–Control Study in Chinese Women

et al. 2020

View full text Add to dashboard Cite

Objective: To investigate the association between metabolic syndrome and breast cancer and to elucidate the potential mechanism underlying this association. Patients and Methods: Based on baseline data drawn from 21 hospitals in 11 provinces of China, we performed a case-control study among 1,127 women (595 cases and 532 controls), divided into premenopausal, and postmenopausal subgroups. Student's t test, Pearson's χ 2 test, and logistic regression analyses were performed to ascertain the association between breast cancer and metabolic syndrome, including all of its components. In addition, we attempted to clarify the potential role of adiponectin in this association. Results: Among the components of metabolic syndrome, abnormal waist circumference was the component that markedly increased breast cancer risk in premenopausal women (OR 1.447, 95% CI 1.043-2.006). Metabolic syndrome with clusters of special risk factors showed an association with breast cancer risk. Among Xiang et al. MetS Increases Breast Cancer Risk all these components of metabolic syndrome, the hypertriglyceridemic-waist (HW) phenotype significantly increased breast cancer risk (OR 1.56, 95% CI 1.02-2.39), regardless of menopausal status, rendering it a strong predictor of breast cancer. Total adiponectin levels and high-molecular-weight adiponectin were reversely associated with metabolic syndrome. In addition, total adiponectin levels among breast cancer patients were much lower than among controls (p = 0.005) only in the HW phenotype subgroup. Furthermore, the HW phenotype was associated with increased risk of estrogen receptor/progesterone receptor-positive (ER+/PR+) breast cancer, with a 95% (OR = 1.95, 95% CI:1.21-3.13) increase. However, there was no significant association between the HW phenotype and both ER+/PR-and ER-/PR-subtypes. These results suggested that low adiponectin levels may be a mechanism that explains the association between the HW phenotype and breast cancer risk. Conclusion: Metabolic syndrome with special cluster factors is related to breast cancer risk; in particular, the HW phenotype can be regarded as a strong predictor of breast cancer. As an important factor involved in fat metabolism, adiponectin may strongly predict metabolic syndrome, especially the HW phenotype and breast cancer. Further research into this mechanism and epidemiological studies are needed. This study provides new evidence for the role of a healthy lifestyle in preventing breast cancer.

show abstract

Section: Introductionmentioning

confidence: 99%

Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case–Control Study in Chinese Women

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Then, body mass index (BMI) (weight in kilograms divided by the square of height) was calculated. BMI between 25 kg/m 2 and 29.9 kg/m 2 is considered to be overweight and BMI greater than 30 was considered to be obese for both men and women [18].…”

Section: Measurements and Questionnairesmentioning

confidence: 99%

Adherence to Medication, Diet and Physical Activity and the Associated Factors Amongst Patients with Type 2 Diabetes

et al. 2020

View full text Add to dashboard Cite

Introduction: The prevalence of type 2 diabetes mellitus (T2D) has increased considerably while the outcome of diabetic management is suboptimal. In order to promote diabetic management, associated factors for adherence to medications, diet, and physical activity (PA) need to be more clearly identified amongst patients with T2D. Methods: This cross-sectional study was conducted on 206 men and 294 women amongst patients with diabetes who were registered in ten special diabetic clinics in Shiraz, Iran from November 2018 to April 2019. Levels of adherence to medication, Mediterranean diet (MD), and physical activity were measured with validated and appropriate questionnaires. Results: Mean age (± SD) was 56.92 ± 0.52 years and 294 (58.8%) were female. Data showed that reduced adherence to medication, MD, and PA increased glycated hemoblobin (HbA1c). Adherence to medication among low, moderate, and high levels was 27.2%, 59.2%, and 13.6%, respectively. Associated factors such as 50-64 years of age, at least 65 years of age, overweight, obese, divorced widow, smoker, and exsmoker had a significant influence on adherence to medication, P = 0.017, P = 0.018, P = 0.008. P = 0.045, P = 0.026, P\0.004, and P = 0.001, respectively. In addition, adherence to MD among low, moderate, and high levels was 5.4%, 77.2%, and 17.4%, respectively. Associated factors such as 50-64 years of age, at least 65 years of age, overweight, obese, and smoker had a significant influence on adherence to MD, P = 0.011, P = 0.046, P = 0.002, P\0.001, and P = 0.032, respectively. Furthermore, adherence to PA among low, moderate, and high levels was 21%, 68.6%, and 10.4%, respectively. Only the non-smoker factor played a significant role in PA adherence, P = 0.010. Conclusion: Levels of adherence to medications, diet, and PA amongst patients with T2D are not within the acceptable range. Recognized associated factors that contribute to adherence might improve diabetes management and allow one to tailor the appropriate message to improve glycemic indices.Enhanced Digital Features To view enhanced digital features for this article go to https://doi.org/10.6084/ m9.figshare.11358593. A. Mirahmadizadeh Key Summary PointsWhy carry out this study?In order to promote diabetic management, the associated factors for adherence to medications, diet, and physical activity (PA) need to be more clearly identified amongst patients with type 2 diabetes (T2D).Although the levels of adherence to medication, diet, and physical activity have been evaluated separately in other studies in patients with T2D, few studies have simultaneously evaluated the adherence to these factors.What was learned from the study?Reduced adherence to medication, Mediterranean diet (MD), and PA increased HbA1c.Adherence to medication among low, moderate, and high levels was 27.2%, 59.2%, and 13.6%, respectively. Associated factors such as 50-64 years of age, at least 65 years of age, overweight, obese, divorced widow, smoker, and exsmoker had a significant influence on adherence to medication...

show abstract

“…Obesity is considered as one of the causes of hyperlipidaemia and CVD risks in T2DM . On the other hand, weight loss is the main recommendation of Adult Treatment Panel III (ATP III) and ADA for T2DM patients . Although calorie restriction and weight loss are definitely essential for overweight people and those with DM, there is no consensus on an ideal diet for these patients …”

Section: Introductionmentioning

confidence: 99%

“…9 On the other hand, weight loss is the main recommendation of Adult Treatment Panel III (ATP III) and ADA for T2DM patients. 10 Although calorie restriction and weight loss are definitely essential for overweight people and those with DM, there is no consensus on an ideal diet for these patients. 4 Consequently, the results of previous studies investigating the effect of the DASH diet on lipid profiles were contradictory.…”

Section: Introductionmentioning

confidence: 99%

Comparison of the effect of Dietary Approaches to Stop Hypertension diet and American Diabetes Association nutrition guidelines on lipid profiles in patients with type 2 diabetes: A comparative clinical trial

Hashemi

Khalifani

Rahimlou

et al. 2019

Nutrition & Dietetics

View full text Add to dashboard Cite

Aim The present study aimed to compare the effects of the Dietary Approaches to Stop Hypertension (DASH) diet and American Diabetes Association (ADA) guidelines on the lipid profiles of patients with type 2 diabetes. Methods In a 12‐week clinical trial, 80 patients with type 2 diabetes aged 18–65 years were randomly allocated into the case (n = 40) and control (n = 40) groups. The case group received the DASH diet and the control group consumed a dietary pattern in accordance with the ADA guidelines. Fasting blood samples were measured for triglyceride (TG), low‐density lipoprotein (LDL), total cholesterol (TC), high‐density lipoprotein (HDL), very low‐density lipoprotein (VLDL) and free fatty acid (FFA). Moreover, physical activity and 24‐hour dietary recall (24 hours) were assessed at baseline and end of the study. Results The DASH diet and diabetic diet (in accordance with the ADA guidelines) for 12 weeks significantly decreased TG, TC and VLDL (P < 0.05). FFA showed a significant decrease in both the groups, which was greater in the cases compared with the control group (P = 0.049). Conclusions Compliance with any DASH or diabetic diet for 12 weeks in patients with type 2 diabetes had beneficial effects on cardiometabolic risks.

show abstract

Assessment of two different diagnostic guidelines criteria (National Cholesterol Education Adult Treatment Panel III [ATP III] and International Diabetes Federation [IDF]) for the evaluation of metabolic syndrome remission in a longitudinal cohort of patients undergoing Roux-en-Y gastric bypass

Cited by 26 publications

References 19 publications

Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case–Control Study in Chinese Women

Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case–Control Study in Chinese Women

Adherence to Medication, Diet and Physical Activity and the Associated Factors Amongst Patients with Type 2 Diabetes

Comparison of the effect of Dietary Approaches to Stop Hypertension diet and American Diabetes Association nutrition guidelines on lipid profiles in patients with type 2 diabetes: A comparative clinical trial

Contact Info

Product

Resources

About